Fig. 5

Prognosis of anti-NMDAR encephalitis. The prognosis of patients at months 1, 6, 12, 24, 36, and 48 is demonstrated. The proportions with good prognosis were 57.2%, 78.8%, 85.9%, 91.4%, 90.9% and 92.3%, respectively